Health & Biotech
Check out the latest Medical Cannabis news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
Here’s why this fundie expects MGC Pharma’s stock price to more than double
Health & Biotech
MGC Pharma makes inroads in the fight against COVID-19, getting a regulatory nod in Germany and a successful trial in India
Health & Biotech
MGC Pharma share price soars after CannEpil+ scores UK-first import deal
Health & Biotech
Creso Pharma expands European footprint with additional hemp seed oil purchase orders
Health & Biotech
Epsilon signs deal with Canadian cannabis products powerhouse The Valens Company
Health & Biotech
Creso Pharma and Red Light Holland call off merger, as NASDAQ beckons
Guides
ASX Cannabis Stocks Guide 2021: Here’s everything you need to know
Health & Biotech
Creso Pharma’s psychedelics subsidiary Halucenex receives Canadian licence approval, targets Phase II trials on PTSD
Health & Biotech
Creso Pharma’s Canadian subsidiary Mernova secures licence for medicinal cannabis in Canada
Health & Biotech
ECS Botanics jumps almost 5pc on $4.5 million Polish deal
Health & Biotech
Cymra secures cultivation permit as it builds a first-mover advantage in cannabis genetics
Health & Biotech
Medibis raises funds for research and cultivation facility, sets eyes on huge medicinal cannabis market
Health & Biotech
Creso Pharma welcomes Senate Democrats’ bid to legalise cannabis
Health & Biotech
Creso Pharma completes acquisition of Canada-based Halucenex, set to enter the US$100 billion psychedelic market
Health & Biotech
Stock Insiders Podcast: Wellnex Life moving from strength to strength after rebrand and latest aquisition
Health & Biotech
Creso Pharma delivers another strong quarter as Connecticut brings a new market opportunity
Health & Biotech
Creso Pharma US shares surge on dual-listing
Health & Biotech
Creso Pharma’s takeover target expands scope of PTSD ‘shroom’ trial beyond military vets
Health & Biotech
Creso Pharma sells hemp products in Ecuador, gears up for the lucrative Latin American market
Health & Biotech
Creso Pharma’s takeover target poised to enter lucrative US market
Health & Biotech
Neurotech hits another key milestone with unique drug therapy in the US$25bn market for multiple sclerosis treatments
Health & Biotech
Weed Week: Europe or North America, where’s the place to be for ASX cannabis stocks?
Health & Biotech
Creso Pharma gets cannabis award in Ontario, increases brand awareness in Canada
Health & Biotech
Creso Pharma secures additional supply of psilocybin, paves the way for future psychedelics products
Health & Biotech
Neurotech just started world’s first THC-less cannabis study in autistic children
Health & Biotech
Weed Week: Finally, a cannabis drug is on Australia’s Pharmaceutical Benefits Scheme
Health & Biotech
MGC Pharma builds on momentum with a new $1 million order
Health & Biotech
Neurotech makes significant progress with world’s first cannabidiol drug for children with autism
Health & Biotech
Hot Pot Stocks: Here are 8 ASX plays that have tripled in the last 12 months
Health & Biotech
MGC Pharma acquires clinical trials research company MediCaNL
Health & Biotech
Incannex granted meeting with FDA over CBD drug cocktail
Health & Biotech
ECS Botanics’ new subsidiary extends supply agreement for its sun-kissed cannabis flower
Health & Biotech
Here’s why cannabis M&A activity is on the rise and only just getting started in Australia
Health & Biotech
1 in 10 COVID survivors in Britain still suffer symptoms; ASX cannabis stock Bod wants to help
News
ASX Small Cap Lunch Wrap: Medical imaging IPO, goldie and BNPL stock finish the week strongly
Stockhead TV
V-Con: Medical cannabis – green grass, green growth
Health & Biotech
WA Cannabis stock Little Green Pharma chosen to supply a significant French medical cannabis trial
Health & Biotech
Creso Pharma books another cannaQIX order in South Africa, as cash stockpile soars
Health & Biotech
MGC Pharma attracts $5m grant for its Malta-based production facility
Health & Biotech
Creso Pharma receives first pet-health cannabis orders in Latin America
Health & Biotech
Althea: TGA pot decision will benefit its flagship CBD product
News
Last Orders: What you might have missed on the ASX today
News
10 at 10: These ASX stocks head the procession this morning
Health & Biotech
Here’s how pot execs think the UN’s big cannabis shift can affect pot stocks in Australia
Health & Biotech
What cannabis investors need to know ahead of the TGA’s decision
Stockhead TV
Why Australia’s medicinal cannabis has the leading edge
Health & Biotech
StockDoc Podcast: Biden win has medicinal cannabis sector on high, EXL perfectly placed
Load More
